Abstract:
PURPOSE: A composition containing sulfuretin is provided to prevent or treat type 1 diabetes and to prevent side effects of the diabetes. CONSTITUTION: A composition for preventing and treating type 1 diabetes contains sulfuretin, isolated from Rhus verniciflura, as an active ingredient. A NF-kappaB inhibitor contains sulfuretin, isolated and purified from Rhus verniciflura, as an active ingredient. An iNOS expression inhibitor contains sulfurein as an active ingredient. A health food for preventing diabetes contains sulfuretin as an active ingredient. The composition additionally contains pharmaceutically or nutritionally acceptable carrier, excipient, diluent, or accessory ingredients.
Abstract:
PURPOSE: A composition containing sulfuretin is provided to prevent or treat type 1 diabetes and to prevent side effects of the diabetes. CONSTITUTION: A composition for preventing and treating type 1 diabetes contains sulfuretin, isolated from Rhus verniciflura, as an active ingredient. A NF-kappaB inhibitor contains sulfuretin, isolated and purified from Rhus verniciflura, as an active ingredient. An iNOS expression inhibitor contains sulfurein as an active ingredient. A health food for preventing diabetes contains sulfuretin as an active ingredient. The composition additionally contains pharmaceutically or nutritionally acceptable carrier, excipient, diluent, or accessory ingredients.
Abstract:
PURPOSE: A composition containing sulfuretin isolated and purified Rhus verniciflua is provided to reduce airway inflammatory response and to treat asthma. CONSTITUTION: A composition for preventing and treating bronchial asthma contains sulfuretin isolated from Rhus verniciflua as an active ingredient. An inhibitor of cytokine immune response contains sulfuretin as an active ingredient. An NF-kappaB activity inhibitor contains sulfuretin as an active ingredient. A composition for preventing and treating airway hyperreactivity contains sulfuretin as an active ingredient.